InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Fluegel Bradley M. Director active across 3 companies, notably NeuroMetrix, Inc.. Aggregated, 7 disclosures have been recorded. Activity tracked since 1 July 2022. The latest transaction was disclosed on 16 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
A declarant associated with American Oncology Network, Inc. and NeuroMetrix, Inc., with 6 filings in total. The 6 sampled filings run from 2022-07-06 to 2024-07-18 and are Attribution transactions, with EUR 22,106.97352912624 and EUR 1,467.441700013425 in buys, and EUR 0 in sells.